FRANKFURT May 6 Diversified holding company
Franz Haniel & Cie. said it has no plans to further reduce its
stake in German drugs distributor Celesio, rebuffing a media
Stock market newsletter Platow Brief earlier reported that
Haniel Chief Executive Stephan Gemkow was considering slashing
its holding in Celesio to just above 25 percent.
A Haniel spokesman said there were no such plans nor talks.
Haniel in November sold a 4.6 percent stake in Celesio to
reduce its debt burden, cutting its stake to 50.01 percent.
(Reporting by Matthias Inverardi and Daniela Pegna; Writing by